共 42 条
[1]
McMurray J.J., Petrie M.C., Murdoch D.R., Et al., Clinical epidemiology of heart failure: Public and private health burden, Eur Heart J, 19, pp. P9-16, (1998)
[2]
Ng M., Fleming T., Robinson M., Et al., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, pp. 766-781, (2014)
[3]
Flegal K.M., Kruszon-Moran D., Carroll M.D., Et al., Trends in obesity among adults in the United States, 2005 to 2014, JAMA, 315, pp. 2284-2291, (2016)
[4]
Body Mass Index by Sex, Age and Educational Attainment Level 2017, (2017)
[5]
Kenchaiah S., Evans J.C., Levy D., Et al., Obesity and the risk of heart failure, N Engl J Med, 347, pp. 305-313, (2002)
[6]
Kenchaiah S., Sesso H.D., Gaziano J.M., Body mass index and vigorous physical activity and the risk of heart failure among men, Circulation, 119, pp. 44-52, (2009)
[7]
Aune D., Sen A., Norat T., Et al., Body mass index, abdominal fatness, and heart failure incidence and mortality: A systematic review and dose-response meta-analysis of prospective studies, Circulation, 133, pp. 639-649, (2016)
[8]
Brouwers F.P., De Boer R.A., Van Der-Harst P., Et al., Incidence and epidemiology of new onset heart failure with preserved vs. Reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND, Eur Heart J, 34, pp. 1424-1431, (2013)
[9]
Ho J.E., Lyass A., Lee D.S., Et al., Predictors of new-onset heart failure: Differences in preserved versus reduced ejection fraction, Circ Heart Fail, 6, pp. 279-286, (2013)
[10]
McMurray J., Ostergren J., Pfeffer M., Et al., Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: Baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme, Eur J Heart Fail, 5, pp. 261-270, (2003)